Analyst Ratings for Par Pharmaceutical (PRX) [Buys]

PRX Rating Summary

  |   Expand Research on PRX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
3/25/2011 BofA/Merrill Lynch Upgrade Buy
(N/A)
N/A
(N/A)
29.33 49.98 70.41% Details
8/5/2010 Caris & Co. Upgrade Buy
(N/A)
N/A
(N/A)
27.53 49.98 81.55% Details
Like PRX Ratings? Also take a look at

PRX Ratings News